共 50 条
Nationwide Evaluation of Quality of Care Indicators for Individuals with Severe Mental Illness and Diabetes Mellitus, Following Israel's Mental Health Reform
被引:0
|作者:
Barasche-Berdah, Deborah
[1
]
Ein-Mor, Eliana
[2
]
Calderon-Margalit, Ronit
[1
,2
]
Rose, Adam J.
[1
,2
]
Krieger, Michal
[2
]
Brammli-Greenberg, Shuli
[1
,2
]
Ben-Yehuda, Arye
[2
]
Manor, Orly
[1
,2
]
Cohen, Arnon D.
[3
]
Bar-Ratson, Edna
[4
]
Bareket, Ronen
[5
,6
,7
]
Matz, Eran
[8
]
Paltiel, Ora
[1
,2
]
机构:
[1] Hebrew Univ Jerusalem, Braun Sch Publ Hlth & Community Med, Hadassah Med Org, Fac Med, POB 12272, IL-92210 Jerusalem, Israel
[2] Natl Program Qual Indicators Community Healthcare, Jerusalem, Israel
[3] Clalit Hlth Serv, 101 Arlozorov St,POB 16250, IL-62098 Tel Aviv, Israel
[4] Maccabi Healthcare Serv, IL-68125 Tel Aviv, Israel
[5] Meuhedet Hlth Fund, 124 Ibn Gvirol St, IL-62038 Tel Aviv, Israel
[6] Tel Aviv Univ, Sackler Sch Med, Dept Family Med, Tel Aviv, Israel
[7] Tel Aviv Univ, Dept Med Educ, Fac Med, Tel Aviv, Israel
[8] Leumit Hlth Fund, 23 Sprinzak St, IL-64738 Tel Aviv, Israel
关键词:
Quality care;
Mental health;
Diabetes mellitus;
Public health;
Health disparities;
ATYPICAL ANTIPSYCHOTICS;
CARDIOVASCULAR RISK;
BIPOLAR DISORDER;
BODYWEIGHT GAIN;
MEDICAL-CARE;
SCHIZOPHRENIA;
PEOPLE;
PREVALENCE;
EPIDEMIOLOGY;
MORTALITY;
D O I:
10.1007/s10597-023-01178-y
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
Diabetes Mellitus (DM) is more common among individuals with severe mental illness (SMI). We aimed to assess quality-of-care-indicators in individuals with SMI following the 2015 Israel's Mental-Health-reform. We analyzed yearly changes in 2015-2019 of quality-of-care-measures and intermediate-DM-outcomes, with adjustment for gender, age-group, and socioeconomic status (SES) and compared individuals with SMI to the general adult population. Adults with SMI had higher prevalences of DM (odds ratio (OR) = 1.64; 95% confidence intervals (CI): 1.61-1.67) and obesity (OR = 2.11; 95% CI: 2.08-2.13), compared to the general population. DM prevalence, DM control, and obesity rates increased over the years in this population. In 2019, HbA1c testing was marginally lower (OR = 0.88; 95% CI: 0.83-0.94) and uncontrolled DM (HbA1c > 9%) slightly more common among patients with SMI (OR = 1.22; 95% CI: 1.14-1.30), control worsened by decreasing SES. After adjustment, uncontrolled DM (adj. OR = 1.02; 95% CI: 0.96-1.09) was not associated with SMI. Cardio-metabolic morbidity among patients with SMI may be related to high prevalences of obesity and DM rather than poor DM control. Effective screening for metabolic diseases in this population and social reforms are required.
引用
收藏
页码:354 / 365
页数:12
相关论文